The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families
✍ Scribed by Maria Isabel Waddington Achatz; Magali Olivier; Florence Le Calvez; Ghyslaine Martel-Planche; Ademar Lopes; Benedito Mauro Rossi; Patricia Ashton-Prolla; Roberto Giugliani; Edenir Inez Palmero; Fernando Regla Vargas; José Claudio Casali Da Rocha; Andre Luiz Vettore; Pierre Hainaut
- Book ID
- 116334123
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 165 KB
- Volume
- 245
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mutations in codon 133 of __p53__, which cause the loss of the Δ133 isoform(s) expression, are very frequent in the Li–Fraumeni (LF) and Li–Fraumeni‐like (LFL) syndromes. In sporadic cancers, silent __p53__ mutations are correlated with exonic splicing enhancers (ESEs) and exonic methyl
## Abstract Germline __TP53__ mutations are found in Li‐Fraumeni syndrome (LFS) patients, predisposed to soft tissue sarcoma and other malignancies. The mutations and succeeding genetic events are thought to cause LFS‐associated cancer, whose genetic alterations have rarely been investigated. Here,